Moreover, based on the evidence from animal studies, lower IGF-1 levels are associated with lower protection against IR, inflammation and liver steatosis, while, treatment with IGF-1 improves liver enzymes, steatosis and fibrosis (115). This evidence concerns the gene IGF1 and fatty liver disease.